Literature DB >> 10607284

Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis.

F Roberts1, C W Roberts, D J Ferguson, R McLeod.   

Abstract

There is considerable controversy as to the roles of parasite proliferation and the inflammatory response in destruction of the retina during Toxoplasma gondii infection. A murine model was used to investigate the role of nitric oxide in pathogenesis of chronic ocular toxoplasmosis. Increased quantities of messenger RNA (mRNA) transcripts for iNOS were detected in the eyes of chronically infected C57BL/6 mice compared with noninfected control mice. Inhibition of nitric oxide (NO) by the addition of Lomega-nitro-L-arginine methyl ester (L-NAME) to the drinking water of infected mice between weeks 4-6 of infection, exacerbated ocular inflammation. The amount of inflammation was assessed semiquantitatively in histological sections of the eye. Eyes from L-NAME treated mice showed a significant increase in inflammation of the retina (P = 0.02), choroid (P = 0.03), and vitreous (P = 0.02) compared with control mice. These results demonstrate a protective role for NO in the control of chronic, ocular toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10607284     DOI: 10.1046/j.1365-3024.2000.00259.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  16 in total

Review 1.  Apoptosis and the balance of homeostatic and pathologic responses to protozoan infection.

Authors:  L Cristina Gavrilescu; Eric Y Denkers
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  A patatin-like protein protects Toxoplasma gondii from degradation in activated macrophages.

Authors:  Dana G Mordue; Casey F Scott-Weathers; Crystal M Tobin; Laura J Knoll
Journal:  Mol Microbiol       Date:  2006-12-11       Impact factor: 3.501

3.  The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice.

Authors:  Elizabeth Charles; Michelle C Callegan; Ira J Blader
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

4.  Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.

Authors:  Sandhya Kortagere; Ernest Mui; Rima McLeod; William J Welsh
Journal:  J Comput Aided Mol Des       Date:  2011-02-26       Impact factor: 3.686

5.  Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6.

Authors:  R E Lyons; J P Anthony; D J Ferguson; N Byrne; J Alexander; F Roberts; C W Roberts
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 6.  Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion.

Authors:  Sini Skariah; Matthew Karmen McIntyre; Dana G Mordue
Journal:  Parasitol Res       Date:  2010-06-01       Impact factor: 2.289

7.  Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii.

Authors:  Kamal El Bissati; Aziz A Chentoufi; Paulette A Krishack; Ying Zhou; Stuart Woods; Jitender P Dubey; Lo Vang; Joseph Lykins; Kate E Broderick; Ernest Mui; Yasuhiro Suzuki; Qila Sa; Stephanie Bi; Nestor Cardona; Shiv K Verma; Laura Fraczek; Catherine A Reardon; John Sidney; Jeff Alexander; Alessandro Sette; Tom Vedvick; Chris Fox; Jeffrey A Guderian; Steven Reed; Craig W Roberts; Rima McLeod
Journal:  JCI Insight       Date:  2016-09-22

8.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12

9.  T. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrest.

Authors:  Samuel L Hutson; Ernest Mui; Karen Kinsley; William H Witola; Michael S Behnke; Kamal El Bissati; Stephen P Muench; Brittany Rohrman; Susan R Liu; Robert Wollmann; Yuko Ogata; Ali Sarkeshik; John R Yates; Rima McLeod
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

Review 10.  Use and abuse of dendritic cells by Toxoplasma gondii.

Authors:  Anna Sanecka; Eva-Maria Frickel
Journal:  Virulence       Date:  2012-11-15       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.